TELA Bio (TELA) EPS (Basic) Growth (3y) (2021 - 2026)
Powered by 
Analysis
TELA Bio (TELA) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 127.72 Bn | 122.50 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 116.88 Bn | 108.06 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 104.10 Bn | 100.62 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 63.74 Bn | 63.20 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.15 Bn | 30.20 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 20.63 Bn | 20.15 Bn | 684.20 Mn | 17.98% |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn | 26.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.88% |
| Mar 31, 2026 | 30.97% |
| Dec 31, 2025 | 65.46% |
| Sep 30, 2025 | 32.93% |
| Jun 30, 2025 | 34.19% |
| Mar 31, 2025 | 30.45% |
| Dec 31, 2024 | 16.14% |
| Sep 30, 2024 | 9.25% |
| Jun 30, 2024 | 3.32% |
| Mar 31, 2024 | 25.85% |
| Dec 31, 2023 | 0.36% |
| Sep 30, 2023 | 4.15% |
| Jun 30, 2023 | 1.90% |
| Mar 31, 2023 | -0.97% |
| Dec 31, 2022 | 46.37% |
| Sep 30, 2022 | 69.71% |
| Jun 30, 2022 | 69.51% |
| Mar 31, 2022 | 69.85% |
| Dec 31, 2021 | 73.47% |
| Sep 30, 2021 | 67.14% |